GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Change In Payables And Accrued Expense

Rising Biosciences (Rising Biosciences) Change In Payables And Accrued Expense : $0.00 Mil (TTM As of . 20)


View and export this data going back to . Start your Free Trial

What is Rising Biosciences Change In Payables And Accrued Expense?

Rising Biosciences's Change In Payables And Accrued Expense for the quarter that ended in . 20 was $0.00 Mil. It means Rising Biosciences's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .

Rising Biosciences's Change In Payables And Accrued Expense for the fiscal year that ended in . 20 was $0.00 Mil. It means Rising Biosciences's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .


Rising Biosciences Change In Payables And Accrued Expense Historical Data

The historical data trend for Rising Biosciences's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Change In Payables And Accrued Expense Chart

Rising Biosciences Annual Data
Trend
Change In Payables And Accrued Expense

Rising Biosciences Quarterly Data
Change In Payables And Accrued Expense

Rising Biosciences Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rising Biosciences Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Rising Biosciences (Rising Biosciences) Business Description

Industry
Traded in Other Exchanges
N/A
Address
1180 Cleveland Road, Sandusky, OH, USA, 44870
Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.

Rising Biosciences (Rising Biosciences) Headlines

From GuruFocus